JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?(!EPINRPE (J( (AEPQ(AT]VGELڮWCSңZJS׏jM\qWvg]mssp SEybL+G^k;;%SRRPIKI@ŠJ((QEr 0̛ͅ0Xw_53m4JF\:tmT64vˌ8>,FhzsKGy-ׁ_8ȷ=?6m-ųso:iLEɁ1oqѵ߸vzܒCf)2 rCFks(QE%Q@Q@J(l-!ZXinڣeƜѬ ">ޣ5[AC~і+($:N1PAiŶh'nGCW^? ΓIcgj Q] =UR9orx?+c 4F:ַ )T -kJC泐yO ׹dz\7ĝMiESUͩ;; r[N\6C]-x6K$|;+⹄%PGufL5VE%QEQE% JSI@Q@a5/Idiqˣ0nV?+K֧GM[;,3RLRdVI'~ P|FOƣ(|9® g]%\7>÷֟oI0[cDyخrl[ռY9G"!tXz5+kG23+9!:Ġ-V%Π!|ۉBCҊBVӴl|d0@8zWOmXEa{kKmqqLw&=6mR[;֒#[5 ˱x^>fP%k&/ B`yVVvn]n1µ~c\.?uA7&Z]ꋰ)QG,ET{Br> \U~C[9][,wǭr[֯Y^,3ݼWM2"@vy^=#"HǏj'&p&sՎ=+FORPE zDP빔⹠vgMVn4SN泘GS0sVJۿrHrN9+Hw;W_\fV "Fj[PHT:*{{f6Y{ڭ}⏷Z>g❓ZItSzSIueu䁓5 y7à<6"V#npqҜ4؇Um7aKO3Mֶ 8n!mrPzB` $R^2#:sCǻdx8E\{iц c%vpY{E%"f\W9")(P@8O~NұViyVr nj[nY-]Ic4G_(Gr:ʱխlmUx(X@23uM37cǮkug&,pK BڳVKqn3`VDKyHN_pSdbNd"x#f#U3XOYb0PAo[r^`uF#tOz\G8jdžT!:akHѾh71t* d#YmnA푊o@nlT 1b18q\\y;P k-an9]7 ([kr;StHJ ֦[}.pT IGi6'YJp2y I4芫=p+c[ӠYm1!S P-$y#vn8iR.ʅJ 99x {PA1Ecqoj+eLmH*[]\奼>ș68!X2`pIh?kOId؎Xp>Ҥ:L$w8&6kQŮ`G綊 %xF]LazS}Y3Iu$aA*K#H|1R2IWQϖȠۮ3ʹT,lnɕU˚"fF zY/)Z02c\mJ^D{?Cl|0Č9iDD t$ֺR  j%-S 0B3Jhm]$\Kz2DїfvB9LU* #6qH >m\ridkܥюX @iro2|Qr׻G c[6p3Y眒,P-(3OzKH\sT޶D7WSZ T0p@3X"+T[iVIdrO'z~hc8iT{VE2_e'1oXDr  0FyCEq?U¶eF\1π_n9PdLc}%sf$šL)^fLŽ4>ɰinzSYaߥIz2o&G4̑*lT'ژYtѱZʞ+K2+ˆG'S~ƭךg]Xη$kl{U \}F@|w?pB5)=cE6kE{jIW`3Pkڊ8UU#?ά!Z I@8ⰻ:Ҝ=jA57 ޞj֕a0{2Ɲw=h-vI\-Gdi( S7=xsgSPY?6<̅Μ!"BOҐ745D&v?HΣ&v@NZ#AΌWlpsYJ㯒@MY G+s gEl+}+\[1SƻM;|isP@_&?P`jXs)(gzԘ9\g$*TP?yk6}{Swc\xT<m*QM[1zDOJ,θ)q޸I\I 6?OCwAcld) ϧ+Yکnq?jq}wG%EՕB usϵ& ;CB џ3tϽ.oP_V8̮HPYA@(8Ivbd  F߼h 0ql˂_q8@1c *Lu"6RݳOhۊ33׿Z+mݚFY H۰|EI?u 6AsО[\SGO Nב𭜝ˎ0wlzQ:6y@Mʼ1ji55+۟El{,MK# (=kA}s_omn59bK~e*18zW+h.'Pmm~U|?#ԭ<,,KtAɥTSƾӠKmCFIּs[դuZb )=8{5hZHOEV!(* SkBּȊ1!]VxHO1;^r+}A_?}'I6vC8#_w;NWޤӨ'^p'zHgu:^#LoLnZwwyяap;؟i2qODOS++;I!=g/ڋ@eR:9ocL6 ic玵.QH?]~In幝HifHA3eDy9j林m/gA*SPv;K;4*^NLl~=I/9tl2  Vō!pUl"3qbqֻmLYSNHgڦnFoZ/$TXn"C>Z߃,K~e|v J᫻q1' 횵}txSڹԜ^TUZ_}$f-aX|Ă#1ֻmbM3_'a$q$WT%sʨ&3N(Ҵ3" Wu\E\e&a@܌xϥNb55slN,a] z܆{03I%Oe]65ܛzɁ!nQYʬ"ᇩ8#h 8T={l+QF[ܸr˭ɬ5Bј\HADRr}Mr$ juVtL{nZit 6VFӴ8$Pt[㏻,'?gqD:Kqfyǥ0+A gI/ޔ/5X)+\T\ᘏTZ']He"w_e,l&$=JҠ `8*r\[[GY<:(i+F7^RH4[un8zMx[Z7,|}ؓڊ%_GK biQJtqG9hQfcwCN~iCYpIH"``Ѻh\uOFpE&0.HRp GAģ! IsۻYHW[;8pkʹN˸d.{SrwHuOߙi_ȚQhb6װrkO6^µ&֭ hÌcWqZAXTSG7ցxȍU#KTK io EAQ$E9$\UhJ+;28 XB:즬H{B@ϡjrݡ<{~upMuzU=G;HrǓrθߩ-:qA/&zdfwCUbIaR ʞ \ZْỞ3Qd : ͌14BxTJZOcZ@a }諶l- ,{?mT鶢 time is considered long term? Is it 5 years, 10 years, or 50 years? The FDA has been studying creatine since it exploded onto the sports scene in 1992. Dr. Mike Stone from Appalachian State University, a leader in the field of Muscle Physiology, has been studying athletes who have been taking creatine for as long as six years. To date, there are no reports of kidney, heart or liver problems.<br>Since there is no documented evidence that creatine is a health hazard, the benefits of accelerated muscle development using creatine, far outweigh at least one alternative - using anabolic steroids. For those concerned about sending the wrong message to young adults, consider this; it is a great service to young people tolet them know there is a viable alternative to using anabolic steroids.<br><br>______________________________________<br><br>Creatine is criticized <br